Federal Cannabis Rescheduling: What's Decided and What's on the Line June 29
Jamie
Head Cultivator
Federal cannabis policy split in two on April 28, 2026. State-licensed medical cannabis and FDA-approved marijuana drugs moved to Schedule III. Adult-use flower at your regular Michigan dispensary is still Schedule I — same federal bucket as heroin on paper. The June 29, 2026 DEA hearing is the next big step: it will weigh whether all cannabis should join Schedule III. Nothing from that hearing is final yet as of June 26. This post covers what's already law, what officials have said leading up to the hearing, and what it does and doesn't change for everyday Michigan consumers.
What's the Current Status of Federal Cannabis Rescheduling? #
As of June 26, 2026, medical cannabis is federally Schedule III. Adult-use cannabis is still Schedule I. A DEA hearing starting June 29 will decide whether to move all marijuana to Schedule III — but that hearing has not produced a final ruling yet.
Think of it as a two-lane highway that already opened one lane:
| Track | Federal Status (June 26, 2026) | What It Covers |
|---|---|---|
| Lane 1 — Already done | Schedule III | FDA-approved marijuana drugs + products made and sold under a state medical marijuana license |
| Lane 2 — Still pending | Schedule I | Adult-use / recreational cannabis, gray-market sales, unlicensed grows |
| Next gate | Hearing June 29–July 15, 2026 | ALJ weighs whether all cannabis should move to Schedule III |
The DOJ announced the split order on April 23, 2026, and it took effect April 28 per the Federal Register. That is real law today — not a proposal.
The June 29 hearing is separate. It is an expedited administrative process to decide the broader question: should recreational cannabis get the same downgrade? The DEA's rescheduling actions page lists the hearing window as no later than July 15, 2026. Until the judge issues a recommendation and the DEA acts on it, adult-use stays Schedule I.
If you only buy recreational flower in Michigan, nothing from the April order changed your federal risk profile. If you hold a medical card and buy from a licensed medical track, the federal picture shifted — though state rules still control what you can buy at the counter.
Schedule I vs Schedule III: Plain-English Catch-Up #
Schedule I means the feds treat a drug as high-risk with no accepted medical use. Schedule III means accepted medical use with moderate abuse potential — more like Tylenol with codeine than heroin.
Congress wrote the Controlled Substances Act in 1970. The DEA's drug scheduling page still lists five tiers. For cannabis shoppers, only two matter right now:
| Schedule | Federal Label | Practical Meaning for Cannabis |
|---|---|---|
| Schedule I | "No accepted medical use, high abuse potential" | Felony territory under federal law; harsh tax rules (280E); hard research access |
| Schedule III | "Accepted medical use, moderate abuse potential" | Recognized medicine; standard business tax deductions for covered operators; easier DEA research registration |
Schedule III is not legalization. It is reclassification. Weed can still be illegal if you are outside the covered categories — same way you cannot buy ketamine at a gas station just because it is Schedule III.
What Schedule III Actually Means Day to Day #
For covered medical products, Schedule III mainly changes taxes, research access, and federal stigma — not whether Michigan's adult-use counter suddenly becomes federally blessed.
Three shifts matter most:
- Taxes — Section 280E blocked normal business deductions for Schedule I cannabis sellers. Medical operators in Schedule III can deduct payroll, rent, and marketing like other businesses. Adult-use operators still eat the 280E penalty until a broader rule passes. Our 280E explainer walks through the numbers.
- Research — Schedule III lowers DEA registration hurdles for studying cannabis in approved settings. The Ohio State Drug Enforcement and Policy Center notes this could unlock more federal funding for clinical work.
- Pharmacy pathway — FDA-approved products like Epidiolex were already legal as prescription drugs. Schedule III aligns the controlled-substance label with that reality.
What Schedule III does not do on its own:
- Force banks to serve cannabis companies (banking law is separate)
- Wipe out Michigan's state licensing system
- Protect recreational buyers at adult-use shops
- Guarantee lower shelf prices — taxes help businesses, not always consumers
What Already Changed on April 28, 2026 #
The DOJ and DEA moved two specific cannabis buckets to Schedule III effective April 28, 2026: FDA-approved marijuana drugs and products made under state medical marijuana licenses. Everything else stayed Schedule I.
Acting Attorney General Todd Blanche issued the order under 21 U.S.C. § 811(d)(1), citing U.S. obligations under the Single Convention on Narcotic Drugs. The Marijuana Policy Project's Q&A breaks the scope into plain terms.
Who Gets Schedule III Protection Today #
Schedule III coverage follows the license and the product — not the shopper's intent at the register.
| Product / Activity | April 28 Status | Notes |
|---|---|---|
| Epidiolex and other FDA-approved marijuana drugs | Schedule III | Prescription pathway unchanged; label now matches |
| State-licensed medical flower, edibles, concentrates | Schedule III | Must stay inside medical license boundaries |
| Medical supply chain (grow, process, transport, dispense) | Schedule III | When conducted under state medical authority |
| Adult-use / recreational products | Schedule I | Explicitly excluded from the order |
| Synthetic THC (not FDA-approved) | Schedule I | Excluded |
| Hemp under federal farm bill definition | Separate rules | Not part of this order |
The order also created a new DEA registration pathway for state-licensed medical entities. Per Duane Morris's April 2026 alert, state credentials can serve as conclusive evidence when applying to manufacture, distribute, or dispense at the federal level.
Legal fights started immediately. Opponents argue the DOJ skipped normal rulemaking steps. Scarinci Hollenbeck's client alert flags expected lawsuits seeking to block or delay the order. For operators, that means the April win is real but not guaranteed forever.
For a deeper timeline, see our Schedule III medical-only breakdown and the full rescheduling guide.
What the June 29 DEA Hearing Is — and Is Not #
The June 29 hearing is a formal evidence review before an administrative law judge (ALJ). It is not a congressional vote, not a ballot measure, and not an instant law change — even if the judge recommends broader Schedule III.
Here's the process in order:
- Hearing runs June 29 through July 15, 2026 (with a July 4 break) at the DEA Hearing Facility in Arlington, Virginia
- Selected parties present evidence and expert testimony
- Chief ALJ Derek C. Julius issues findings and a recommended decision
- DEA Administrator considers the recommendation and may issue a final rule
- Courts can still review whatever the agency does
The Gibson Dunn alert confirms Julius replaced a retired judge from the earlier 2024 process. The prior hearing track was terminated to make room for this faster timeline.
What the hearing is deciding: whether all marijuana — including adult-use — should move from Schedule I to Schedule III.
What it is NOT deciding: Michigan dispensary hours, Detroit licensing, or whether you personally should use cannabis. State law still runs the retail experience.
Pre-Hearing Legal Fights: Who Gets a Seat at the Table #
The DEA picked seven hearing participants as of late June 2026. Legal filings show pro-rescheduling groups fought to get in — and lost a key motion on June 24.
According to Ropes & Gray's June 2026 update:
- On June 24, 2026, the ALJ said he would not disturb the DEA's participant picks
- Parties that wanted to argue for rescheduling were among those deemed ineligible
- Industry reports (Vicente LLP pre-hearing analysis) describe the seven selected participants as opposed to rescheduling — groups like Smart Approaches to Marijuana and the National Drug & Alcohol Screening Association
That matters because administrative hearings are not town halls. The evidence record shapes what the judge can recommend. If the lineup skews anti-rescheduling, supporters worry the record will be one-sided — though the DOJ and DEA still present their own case.
Access note: Frantz Ward reports the hearing is not livestreamed or televised. Observers must attend in person in Arlington. For most Michigan consumers, news coverage and agency filings — not a C-SPAN feed — will be the source.
We previewed the stakes in our June hearing preview.
What Officials Have Said So Far #
Federal officials have framed cannabis as having accepted medical use — but they drew a hard line keeping adult-use in Schedule I until the June hearing finishes.
No partisan spin here. This is what agencies and appointees put on the record before June 29:
| Speaker / Agency | What They Said | Source |
|---|---|---|
| DOJ / Acting AG Todd Blanche | Rescheduled FDA-approved and state-licensed medical marijuana to Schedule III under Single Convention authority; initiated expedited hearing for broader rescheduling | DOJ press release, April 2026 |
| DEA | Published hearing notice for June 29–July 15; terminated prior hearing track to expedite | DEA rescheduling actions |
| DOJ (order text) | Marijuana not in an FDA drug and not under a state medical license remains Schedule I | Federal Register, April 28, 2026 |
| Treasury / IRS (industry guidance context) | Tax treatment for Schedule III cannabis operators will need formal IRS guidance; 280E relief timing may depend on tax year | Treasury press release SB0471 |
| Ohio State DEPC (independent analysis) | April order is a dual framework — medical down, recreational up in the air pending hearing | OSU policy analysis |
What opponents said pre-hearing: Groups selected for the hearing — including Smart Approaches to Marijuana — argue rescheduling goes too far and that cannabis lacks the safety profile for Schedule III. Their pre-hearing statements are filed on the DEA docket. We are not endorsing either side; that is the public record.
What supporters said pre-hearing: Medical operators and advocacy groups (many not selected as participants) argue full Schedule III aligns federal law with state markets where adult-use is legal in 24+ states. They point to HHS's 2023 recommendation that cannabis belongs in Schedule III.
Bottom line from the record: Even the government agrees medical cannabis has accepted use today. The fight is whether that logic extends to the recreational products most Michigan shoppers actually buy.
What Changes for Patients, Consumers, and Businesses #
If you are in the medical track, April's Schedule III order already unlocks tax relief and a clearer federal status. If you are in adult-use, you are waiting on the June hearing — and even a win there would not fix banking overnight.
Medical Patients #
- Federal status: Products bought with a valid medical card from a licensed medical operator are Schedule III as of April 28
- Practical effect: Less federal felony exposure when you stay inside the medical lane; state rules still govern purchase limits and product types
- Pharmacy access: Still limited to FDA-approved drugs like Epidiolex for now — your dispensary flower is not a CVS pickup
Medical Cannabis Businesses #
- 280E relief: Can deduct ordinary business expenses. Connor PLLC's 2026 analysis estimates industry-wide cash-flow gains in the billions if medical operators fully exit 280E
- Tax timing caveat: Pillsbury's tax alert warns relief might not hit every operator's 2026 return — IRS guidance still pending via Treasury SB0471
- DEA registration: New pathway to register grows and dispensaries federally using state licenses
Adult-Use Businesses and Consumers #
- No April relief: Recreational operators still pay 280E. Consumers still buy a Schedule I product under federal law
- Hearing upside: If broader Schedule III passes, adult-use could eventually get the same tax and research benefits — but that is if, not when
Researchers #
- Lower DEA barriers for Schedule III studies
- More federal funding eligibility for cannabis trials in approved settings
| Group | Changed April 28? | Could Change After Hearing? |
|---|---|---|
| Medical card holders | Yes — federal Schedule III | Mostly settled |
| Medical licensees | Yes — taxes + registration | Mostly settled |
| Adult-use shoppers | No | Possibly, if broader rule passes |
| Adult-use operators | No | Possibly — 280E + registration |
| Banks serving cannabis | No | Still needs separate banking law |
What Does NOT Change (Including Recreational) #
Recreational cannabis remains Schedule I federally as of June 26, 2026. Rescheduling medical products did not legalize adult-use, fix banking, or erase state licensing requirements.
The DOJ order text is explicit: marijuana outside FDA-approved drugs and state medical licenses stays in Schedule I. Seyfarth's employer-focused analysis calls this a dual framework — two federal labels for the same plant depending on the license.
Still unchanged after April (and still unchanged until a broader final rule):
- Adult-use possession and sales — federally illegal even in legal states
- Interstate cannabis shipping — still banned
- Banking access — Schedule III did not repeal the core conflicts that keep most banks away. See why cannabis is still mostly cash
- Employer drug testing — federal Schedule I label still supports zero-tolerance policies at many workplaces; check your union contract or HR handbook
- Home grows without a medical card — Schedule I activity
- Gun ownership rules — federal form questions about illegal drug use still snag cannabis consumers in many cases
Headline trap: "Cannabis is Schedule III now" is only half true. Most Michigan dispensary revenue comes from adult-use. That slice is still Schedule I until — and unless — the June hearing produces a broader final rule that survives court challenges.
Michigan Angle: Medical vs Adult-Use at the Dispensary #
Michigan lets most dispensaries serve both medical card holders and adult-use customers — but federally, those two checkout lanes are on different schedules as of June 26, 2026.
The Michigan Cannabis Regulatory Agency regulates both programs. At the counter, you might not see a difference. At the federal level, the April order draws a bright line:
| Michigan Purchase Type | State Status | Federal Status (June 26, 2026) |
|---|---|---|
| With valid medical marijuana card | Legal under state law | Schedule III (if product from licensed medical track) |
| Adult-use 21+ without card | Legal under state law | Schedule I |
| Unlicensed street purchase | Illegal | Schedule I |
What this means for Detroit-area shoppers:
- Medical card holders: You are in the category the DOJ already moved to Schedule III. Keep your card current and buy from licensed provisioning centers. That is the federal safe lane today.
- Adult-use only: Your purchase is legal under Michigan law but still Schedule I federally — same as before April 28. The June hearing is your relevant watch point.
- Dual-license shops: Many operators run medical and adult-use side by side. Only the medical-track inventory and sales fall under Schedule III. MPP's federal Q&A stresses compliance with state medical license boundaries — not just what the front door sign says.
Tax ripple: Michigan medical operators may see relief from 280E first. Adult-use operators still face the punitive tax math until broader rescheduling lands. That affects reinvestment, hiring, and — indirectly — what lands on shelves. It does not automatically mean cheaper eighths next week.
Local policy unchanged: Detroit social equity rules, CRA testing requirements, and municipal licensing are untouched by the federal hearing. This is a federal tax-and-status layer on top of state law — not a replacement for it.
At Divine Toke, we grow sun-grown organic flower under Michigan's licensed framework. Wherever federal lines land, clean inputs and transparent lab results still matter for the folks actually smoking it.
What's Next After the Hearing #
The June 29–July 15 hearing produces a recommendation — not a law. Expect months of agency review and court fights before adult-use status is truly settled.
Realistic timeline based on how DEA rescheduling works:
| Stage | Earliest Timing | What Happens |
|---|---|---|
| Evidentiary hearing | June 29–July 15, 2026 | Testimony and cross-examination on broader Schedule III |
| ALJ recommendation | Weeks to months after July 15 | Julius issues proposed findings to DEA |
| DEA final rule | Unknown — not automatic | Administrator accepts, rejects, or modifies the recommendation |
| Judicial review | Likely | Opponents already telegraphed APA and statutory challenges (Harris Beach Murtha alert) |
| IRS/Treasury guidance | Parallel track | Clarifies when 280E relief applies to medical operators' 2026 returns |
Three scenarios to watch:
- Broader Schedule III approved — Adult-use joins medical in Schedule III. Medical tax relief expands to recreational operators. Still not full legalization.
- Status quo upheld for adult-use — Medical stays Schedule III; recreational stays Schedule I. Michigan adult-use continues under state law only.
- Courts block the April medical order — Long-shot but possible. Would throw medical operators back into legal uncertainty while fights continue.
What you should do as a consumer:
- Do not panic-buy or hoard based on hearing hype — state shelves stay open either way
- If you have qualifying conditions, talk to a doctor about whether a medical card makes sense for the federal Schedule III lane
- Track official sources — DEA rescheduling page and DOJ press room — not viral posts claiming "weed is legal now"
We will keep updating the rescheduling guide cluster as filings drop. Policy moves slow. Your day-to-day Michigan purchase rules probably will not flip on a single hearing day.
Frequently Asked Questions #
Has the DEA rescheduled all cannabis to Schedule III? #
No — only medical-track and FDA-approved products are Schedule III as of June 26, 2026. The April 28 Federal Register order covers state-licensed medical marijuana and FDA-approved drugs. Adult-use cannabis remains Schedule I until a broader final rule passes — if it passes.
Is recreational cannabis still federally illegal in 2026? #
Yes. The DOJ's April 2026 announcement states that marijuana outside medical licenses and FDA-approved products stays Schedule I. Michigan adult-use is legal under state law but not federally.
Does Schedule III mean my Michigan dispensary purchase is legal federally? #
Only if you are buying on the medical track with a valid card from a licensed medical operator. Adult-use purchases remain Schedule I federally even when Michigan says they are fine. The license type — not the dispensary's brand name — controls the federal label.
Will rescheduling lower dispensary prices? #
Not directly, and not immediately. Schedule III mainly helps business taxes (280E relief for medical operators). Connor PLLC notes cash-flow gains for operators, but savings may reinvest in growth rather than drop shelf prices. Adult-use shoppers see no tax relief until broader rescheduling.
Does Section 280E still apply to adult-use cannabis businesses? #
Yes, as of June 26, 2026. Only Schedule III-covered medical activity escapes 280E. Recreational operators still cannot deduct normal business expenses. Our 280E guide explains why that tax hits prices indirectly.
Will banks finally work with cannabis companies after rescheduling? #
Not from the April medical order alone. STMC's 2026 analysis says banking restrictions persist because cannabis remains heavily regulated and federally contested. Separate legislation — like past SAFE Banking proposals — would still be needed for mainstream banking.
What is the June 29 hearing actually deciding? #
Whether all marijuana — including adult-use — should move from Schedule I to Schedule III. Medical and FDA-approved products are already Schedule III. The DEA hearing notice sets the window as June 29 through July 15, 2026.
Can I watch the DEA hearing online? #
No. Frantz Ward's June 2026 briefing confirms the hearing is not livestreamed. Observers must attend in person in Arlington, Virginia. News outlets and law firms publish summaries after each session.
How does Schedule III affect Michigan medical card holders? #
Your federally recognized medical purchases fall under Schedule III as of April 28, 2026 — when made through licensed medical channels. Keep your card active, buy from licensed provisioning centers, and follow state purchase limits. Schedule III does not replace Michigan's card system; it adds a federal layer that finally matches medical reality.
When will we know the hearing outcome? #
Not until after July 15, 2026 at the earliest — and probably later. The ALJ must issue a recommendation, then the DEA Administrator acts. Gibson Dunn notes any final rule will likely face court review. There is no same-day verdict.
The Bottom Line for Michigan Shoppers #
Medical cannabis is federally Schedule III today. Adult-use is not. The June 29 hearing starts the fight over the rest — but nothing changes at the register until a final rule survives the courts.
If policy headlines make your head spin, anchor on three facts:
- April 28 already happened — medical track and FDA drugs are Schedule III (Federal Register)
- Your recreational eighth is still Schedule I until a broader rule lands
- The hearing is a process, not a switch — recommendations, agency action, and lawsuits still ahead
For deeper context, read our June 29 hearing preview, the Schedule III medical-only explainer, and the full rescheduling guide.
If you are curious how cleaner, sun-grown flower fits into a regulated Michigan market — medical or adult-use — that is what we focus on at Divine Toke. Policy shifts in Washington. What you put in your body still comes down to source, lab results, and knowing which lane you are buying in.
